Hercules Capital offers a forward P/E of 7.8x, a PEG of 0.70, and analysts implying roughly 25% upside — set against operating margins of 60% and a Rule of 40 score of 63 — but a confirmed technical downtrend with a declining 200-day moving average and negative volume accumulation argues for holding rather than adding until the technical picture improves.
Thesis pillars
- Attractive Valuation Analyst Upside→Stable
- Consistent Earnings Delivery→Stable
- Confirmed Technical Downtrend Headwind↓Deteriorating
- +1 more pillar — see the Why tab for full reasoning
Pillars as of Jul 3, 2026, based on the 10-K filed Feb 12, 2026· older than 90 days
Hercules Capital, Inc. (HTGC) Stock Analysis
Range Bound setup
Financial Services · Asset Management
Sell if holding. At $16.41, A.R:R 0.7:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 3.4%; Leverage penalty (D/E 1.1): -0.5.
Hercules Capital is an internally managed BDC regulated under the Investment Company Act of 1940 that provides senior secured loans and Structured Debt to venture capital-backed and institutional-backed companies in technology and life sciences sectors. The company has... Read more
Sell if holding. At $16.41, A.R:R 0.7:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 3.4%; Leverage penalty (D/E 1.1): -0.5. Chart setup: RSI 51 mid-range, Bollinger mid-band. Score 5.8/10, moderate confidence.
Passes 4/7 gates (clean insider activity, earnings proximity 99d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: aggressive.
About Hercules Capital, Inc.
About Hercules Capital, Inc.
Hercules Capital has originated over $25.0 billion in commitments since inception through December 31, 2025, investing in venture capital-backed and institutional-backed technology and life sciences companies as a BDC regulated under the Investment Company Act of 1940. Portfolio fair value at year-end was approximately 87.1% concentrated in five industries, led by Application Software (24.3%) and Drug Discovery & Development (23.3%). The company held warrant and equity securities in 164 portfolio companies, with 97.9% of loans priced at floating rates of approximately 7% to 14%.
Hercules earns investment income primarily from interest and fees on Structured Debt—senior secured term loans with embedded warrants, equity options, or conversion rights—carrying maturities of 36 to 48 months. As an internally managed BDC, the company incurs operating costs directly rather than paying an external adviser, avoiding the management fee structure of externally managed peers. Income is supplemented by exit fees, balloon payment fees, commitment fees, and prepayment fees, while warrant and equity co-investments provide upside exposure at portfolio company liquidity events. The 1940 Act requires a minimum 150% asset-coverage ratio on borrowings, constraining available debt financing. An Adviser Subsidiary—separately registered as a registered investment adviser—manages third-party funds for external investors, generating supplemental advisory fee income. The company focuses on companies backed by established venture capital and private equity sponsors; as of December 31, 2025, debt investments targeted total annualized returns of 10% to 20%.
Show full overview
The 87.1% portfolio concentration across five technology and life sciences sectors creates correlated default risk the 10-K explicitly identifies: a downturn in any heavily concentrated sector could materially affect Hercules more than a diversified portfolio would. The Drug Discovery & Development sector at 23.3% of fair value is subject to binary FDA approval outcomes, patent expiration, and third-party payer reimbursement changes. The Application Software sector at 24.3% faces subscription renewal volatility and AI-driven competitive disruption the 10-K names specifically. Compounding this, Hercules is classified as non-diversified under the 1940 Act, meaning no regulatory minimum diversification requirement constrains single-issuer exposure beyond its RIC tax requirements.
See also: Financial Services · Asset Management
From Hercules Capital, Inc.'s most recent 10-K filing, extracted June 10, 2026.
Recent developments
updated Oct 28, 2026Recent Developments — Hercules Capital, Inc.
Latest news
- NEWS What to expect from Hercules Capital’s (HTGC) Q3 earnings - Yahoo Finance — Yahoo Finance Oct 28, 2026 neutral
- NEWS Dividend Payout May Change The Bull Case For Hercules Capital (HTGC) - Simply Wall St — Simply Wall St Oct 28, 2026 neutral
- NEWS What to expect from Hercules Capital’s (HTGC) Q3 earnings - StockStory — StockStory Oct 28, 2026 neutral
- NEWS What to expect from Hercules Capital’s (HTGC) Q3 earnings - TradingView — TradingView Oct 28, 2026 neutral
- NEWS Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Third Quarter 2026 - Yahoo Finance — Yahoo Finance Oct 27, 2026 positive
Latest item Oct 28, 2026 · Generated 2026-11-04T11:44:35Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- LOWloan_portfolioApplication Software industry24%10-K Item 1A: 'approximately 87.1% of the fair value of our portfolio comprised investments in five industries: 24.3% comprised investments in the "Application Software" industry'
- LOWloan_portfolioDrug Discovery & Development industry23%10-K Item 1A: 'approximately 87.1% of the fair value of our portfolio ... 23.3% comprised investments in the "Drug Discovery & Development" industry'
- LOWloan_portfolioHealthcare Services, Other industry19%10-K Item 1A: 'approximately 87.1% of the fair value of our portfolio ... 18.8% comprised investments in the "Healthcare Services, Other" industry'
- LOWloan_portfolioSystem Software industry11%10-K Item 1A: 'approximately 87.1% of the fair value of our portfolio ... 10.6% in the "System Software" industry'
- LOWloan_portfolioConsumer & Business Services industry10%10-K Item 1A: 'approximately 87.1% of the fair value of our portfolio ... 10.1% comprised investments in the "Consumer & Business Services" industry'
Material Events(8-K, last 90d)
- 2026-05-04Item 5.02MEDIUMCFO Seth H. Meyer (CFO since March 2019) transitions to President effective May 18, 2026, continuing to report to CEO Scott Bluestein. Andrew Olson, age 43, named to leadership team effective May 18, 2026 (successor CFO role implied; body truncated).SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. At $16.41, A.R:R 0.7:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 3.4%; Leverage penalty (D/E 1.1): -0.5. Chart setup: RSI 51 mid-range, Bollinger mid-band. Prior stop was $15.83. Score 5.8/10, moderate confidence.
Analyst target: $16.96 (+3.4% upside). Prior stop was $15.83. Stop-loss: $15.83.
Thin upside margin: 3.4%; Leverage penalty (D/E 1.1): -0.5; Consecutive earnings misses (2).
Hercules Capital, Inc. trades at a P/E of 8.8 (forward 8.4). TrendMatrix value score: 7.7/10. Verdict: Sell.
15 analysts rate HTGC, with a consensus score of 4.2/5. 9 analysts publish price targets averaging $20.
What does Hercules Capital, Inc. do?Hercules Capital is an internally managed BDC regulated under the Investment Company Act of 1940 that provides senior...
Hercules Capital is an internally managed BDC regulated under the Investment Company Act of 1940 that provides senior secured loans and Structured Debt to venture capital-backed and institutional-backed companies in technology and life sciences sectors. The company has originated over $25.0 billion in commitments since inception through December 31, 2025, earning investment income from floating-rate loans (97.9% of portfolio) priced at approximately 7% to 14%.